These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 583162

  • 1. Pharmacokinetics and relative bioavailability of oral theophylline capsules.
    Lesko LJ, Canada AT, Eastwood G, Walker D, Brousseau DR.
    J Pharm Sci; 1979 Nov; 68(11):1392-4. PubMed ID: 583162
    [Abstract] [Full Text] [Related]

  • 2. Bioavailability studies of theophylline ethylcellulose microcapsules prepared by using ethylene-vinyl acetate copolymer as a coacervation-inducing agent.
    Lin SY, Yang JC.
    J Pharm Sci; 1987 Mar; 76(3):219-23. PubMed ID: 3585738
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
    Schulz HU, Steinijans VW, Gabel H.
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dose dependency for absorption and elimination rates of theophylline. Implications for studies of bioavailability.
    Milavetz G, Weinberger M, Vaughan L.
    Pharmacotherapy; 1984 Nov; 4(4):216-20. PubMed ID: 6483638
    [Abstract] [Full Text] [Related]

  • 13. Comparative pharmacokinetic analysis of a novel sustained-release dosage form of theophylline in humans.
    Raz I, Bialer M, Salame K, Bar-On H.
    Eur J Clin Pharmacol; 1984 Nov; 26(3):401-3. PubMed ID: 6734702
    [Abstract] [Full Text] [Related]

  • 14. Time-dependent absorption of theophylline in man.
    Watanabe H, Nakano S, Nagai K, Ogawa N.
    J Clin Pharmacol; 1984 Nov; 24(11-12):509-14. PubMed ID: 6511990
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of antacid on bioavailability of theophylline from rapid and timed-release drug products.
    Shargel L, Stevens JA, Fuchs JE, Yu AB.
    J Pharm Sci; 1981 Jun; 70(6):599-602. PubMed ID: 7252799
    [Abstract] [Full Text] [Related]

  • 17. Dissolution and bioavailability studies of whole and halved sustained-release theophylline tablets.
    Simons KJ, Frith EM, Simons FE.
    J Pharm Sci; 1982 May; 71(5):505-11. PubMed ID: 7097493
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The absolute bioavailability of oral theophylline in patients with spinal cord injury.
    Segal JL, Brunnemann SR, Gordon SK, Eltorai IM.
    Pharmacotherapy; 1986 May; 6(1):26-9. PubMed ID: 3952003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.